<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">diaendo</journal-id><journal-title-group><journal-title xml:lang="ru">Сахарный диабет</journal-title><trans-title-group xml:lang="en"><trans-title>Diabetes mellitus</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0351</issn><issn pub-type="epub">2072-0378</issn><publisher><publisher-name>Endocrinology research centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/DM13200</article-id><article-id custom-type="elpub" pub-id-type="custom">diaendo-13200</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original Studies</subject></subj-group></article-categories><title-group><article-title>Клинико-лабораторные и генетические особенности семейных форм сахарного диабета 1 типа</article-title><trans-title-group xml:lang="en"><trans-title>Clinical, bio­chemical and genetic characteristics of familial forms of type 1 diabetes</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5463-0425</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зуфарова</surname><given-names>Ю. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Zufarova</surname><given-names>I. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зуфарова Юлдуз Муроджоновна; Researcher ID: AGE-4004-2022.</p><p>117036, Москва, ул. Дм. Ульянова, д. 11</p></bio><bio xml:lang="en"><p>Iulduz M. Zufarova - MD; Researcher ID: AGE-4004-2022.</p><p>11 Dm. Ulyanova street, 117036 Moscow</p></bio><email xlink:type="simple">yulduzzufarova@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4316-8546</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лаптев</surname><given-names>Д. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Laptev</surname><given-names>D. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лаптев Дмитрий Никитич, д.м.н..; Researcher ID: O-1826-2013; Scopus Author ID: 24341083800</p><p>Москва</p></bio><bio xml:lang="en"><p>Dmitry N. Laptev - MD, PhD</p><p>Moscow</p></bio><email xlink:type="simple">laptevdn@ya.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7045-8215</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Минниахметов</surname><given-names>И. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Minniahmetov</surname><given-names>I. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Минниахметов Илдар Рамилевич - к.б.н.</p><p>Москва</p></bio><bio xml:lang="en"><p>Ildar R. Minniakhmetov - PhD in Biology.</p><p>Moscow</p></bio><email xlink:type="simple">minniakhmetov@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8643-850X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хусаинова</surname><given-names>Р. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Khusainova</surname><given-names>R. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хусаинова Рита Игоревна - д.б.н. ; Researcher ID: E-6061-2014; Scopus Author ID: 6602798130.</p><p>Москва</p></bio><bio xml:lang="en"><p>Rita I. Khusainova -PhD in Biology ; Researcher ID: E-6061-2014; Scopus Author ID: 6602798130.</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1172-3557</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Попов</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Popov</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Попов Сергей Владимирович - к.б.н.</p><p>Москва</p></bio><bio xml:lang="en"><p>Sergey V. Popov, PhD in Biology.</p><p>Moscow</p></bio><email xlink:type="simple">swpopov73@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7821-3979</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Титович</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Titovich</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Титович Елена Витальевна - к.м.н.; Researcher ID: AAO-2567-2020; Scopus Author ID: 6507024916.</p><p>Москва</p></bio><bio xml:lang="en"><p>Elena V. Titovich - MD, PhD; Researcher ID: AAO-2567-2020; Scopus Author ID: 6507024916.</p><p>Moscow</p></bio><email xlink:type="simple">lenatitovich@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7021-1151</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Еремина</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Eremina</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Еремина Ирина Александровна - к.м.н. ; Researcher ID: S-3979-2016; Scopus Author ID: 6701334405.</p><p>Москва</p></bio><bio xml:lang="en"><p>Irina A. Eremina - MD, PhD; Researcher ID: S-3979-2016; Scopus Author ID: 6701334405.</p><p>Moscow</p></bio><email xlink:type="simple">ieremina58@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5507-4627</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петеркова</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Peterkova</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Петеркова Валентина Александровна - д.м.н., профессор, академик РАН.</p><p>Москва</p></bio><bio xml:lang="en"><p>Valentina A. Peterkova - PhD, Professor, Academician of the RAS.</p><p>Moscow</p></bio><email xlink:type="simple">peterkovava@hotmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГНЦ РФ ФГБУ «Национальный медицинский исследовательский центр эндокринологии»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Endocrinology Research Centre</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>17</day><month>01</month><year>2025</year></pub-date><volume>27</volume><issue>6</issue><fpage>520</fpage><lpage>527</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Зуфарова Ю.М., Лаптев Д.Н., Минниахметов И.Р., Хусаинова Р.И., Попов С.В., Титович Е.В., Еремина И.А., Петеркова В.А., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Зуфарова Ю.М., Лаптев Д.Н., Минниахметов И.Р., Хусаинова Р.И., Попов С.В., Титович Е.В., Еремина И.А., Петеркова В.А.</copyright-holder><copyright-holder xml:lang="en">Zufarova I.M., Laptev D.N., Minniahmetov I.R., Khusainova R.I., Popov S.V., Titovich E.V., Eremina I.A., Peterkova V.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.dia-endojournals.ru/jour/article/view/13200">https://www.dia-endojournals.ru/jour/article/view/13200</self-uri><abstract><sec><title>ОБОСНОВАНИЕ</title><p>ОБОСНОВАНИЕ. Семейные формы сахарного диабета 1 типа (СД1) представляют особый интерес в связи с высокой концентрацией заболевания, что может быть обусловлено особыми генетическими и средовыми факторами. Их изучение может позволить лучше понять и выявить новые иммунологические и генетические особенности СД1.</p></sec><sec><title>ЦЕЛЬ</title><p>ЦЕЛЬ. Изучить клинико-лабораторные и генетические особенности семейных форм СД1.</p></sec><sec><title>МАТЕРИАЛЫ И МЕТОДЫ</title><p>МАТЕРИАЛЫ И МЕТОДЫ. Одноцентровое одномоментное исследование, включающее 267 пациентов с семейной формой СД1, и 681 пациента со спорадической формой СД1, госпитализированных в ФГБУ «НМИЦ эндокринологии» МЗ РФ в 2016–2023 гг., у которых проведена оценка клинических, лабораторных и генетических параметров.</p></sec><sec><title>РЕЗУЛЬТАТЫ</title><p>РЕЗУЛЬТАТЫ. Медиана возраста манифестации была значимо ниже у детей с семейной формой СД1 (5,2 [3,0; 8,0] и 6,4 [3,6; 9,2] соответственно, p&lt;0,001). Острая манифестация заболевания в состоянии кетоза или диабетического кетоацидоза (ДКА) отмечалась чаще в группе со спорадической формой СД1 (90,3% vs 74%, p&lt;0,001). Частота ДКА в дебюте заболевания в группе сибсов, заболевших в семье первыми, составила 50,5%, в группе сибсов, заболевших вторыми и третьими, — 19,5%, в то время как у детей из семей, где один или оба родителя имеют СД1, — 21% (p&lt;0,001). У детей с семейной формой СД1 чаще выявлялись антитела IAA и GAD (p&lt;0,013 и p&lt;0,003 соответственно). Значимых различий в показателях метаболической компенсации СД1 в исследуемых группах не отмечалось. Предрасполагающие HLA-гаплотипы DRB1*04-DQA1*03:03-DQB1*03:02 и DRB1*07-DQA1*02:01-DQB1*02:02 чаще встречались при семейной форме СД1 (p&lt;0,001 и p&lt;0,001), в то время как протекторный гаплотип DRB1*08-DQA1*04:01-DQB1*04:02 — при спорадической форме.</p></sec><sec><title>ЗАКЛЮЧЕНИЕ</title><p>ЗАКЛЮЧЕНИЕ. Семейные формы СД1 характеризуются более ранним возрастом, меньшим, но все еще значимым риском ДКА при манифестации заболевания, а также особенностями иммунологического профиля и распределения предрасполагающих и защитных HLA-гаплотипов. Полученные данные будут способствовать улучшению прогнозирования рисков и дальнейшим исследованиям в области изучения патогенеза СД1.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>BACKGROUND</title><p>BACKGROUND: Familial clustering of type 1 diabetes (T1D) highlights the importance of genetic and environmental factors in the pathophysiology of diabetes mellitus (DM). It could be the key to understanding of new immunological and genetic characteristics of T1D.</p></sec><sec><title>AIM</title><p>AIM: To study the clinical, biochemical, immunological and genetic characteristics of children with familial forms of T1D.</p></sec><sec><title>MATERIALS AND METHODS</title><p>MATERIALS AND METHODS: A single-center cross-sectional study included 267 patients with familial T1D and 681 patients with sporadic T1D. Clinical and metabolic characteristics, beta cell autoantibodies and HLA class II genetics from patients with T1D hospitalized to Endocrinology Research Centre Moscow between 2016 and 2023 were analyzed.</p></sec><sec><title>RESULTS</title><p>RESULTS: The median age of onset of DM was significantly lower in children with familial T1D (5,2 [3,0; 8,0] vs 6,4 [3,6; 9,2], p&lt;0,001). Children with sporadic T1D had diabetic ketosis or diabetic ketoacidosis (DKA) at presentation more frequently (90,3% vs 74%, p&lt;0,001). Among the sib-pair groups 50,5% of first-affected siblings and 19,5% of second- and third-affected siblings had DKA at presentation, while in children from parent-offspring subgroup DKA episodes were observed in 21% of patients (p&lt;0,001). IAA and GAD antibodies were more frequent in familial cases (p&lt;0,013, p&lt;0,003). In our groups, no significant differences in metabolic compensation of the T1D were found. HLA haplotypes associated with an increased disease risk DRB1*04-DQA1*03:03-DQB1*03:02 and DRB1*07-DQA1*02:01-DQB1*02:02 were more common in children with familial T1D (p&lt;0.001 and p&lt;0.001), while the protective haplotype DRB1*08-DQA1*04:01-DQB1*04:02 was more frequent in sporadic forms.</p></sec><sec><title>CONCLUSION</title><p>CONCLUSION: Due to our study familial forms of T1D are characterized by an earlier age of onset, a smaller risk of DKA at presentation, as well as features of the immunological profile and predisposing and protective HLA haplotypes presentation. We believe more studies are required in the future to look for risk factors and pathogenesis unserstanding.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>сахарный диабет 1 типа</kwd><kwd>дети</kwd><kwd>манифестация</kwd><kwd>аутоантитела</kwd><kwd>HLA</kwd></kwd-group><kwd-group xml:lang="en"><kwd>type 1 diabetes</kwd><kwd>children</kwd><kwd>type 1 diabetes onset</kwd><kwd>autoantibodies</kwd><kwd>HLA</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнено при поддержке Министерства науки и высшего образования Российской Федерации (соглашение №075-15-2024-645)</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Parkkola A, Härkönen T, Ryhänen SJ, et al. Extended family history of type 1 diabetes and phenotype and genotype of newly diagnosed children. Diabetes Care. 2013. doi: https://doi.org/10.2337/dc12-0445</mixed-citation><mixed-citation xml:lang="en">Parkkola A. et al. Extended Family History of Type 1 Diabetes and Phenotype and Genotype of Newly Diagnosed Children // Diabetes Care. 2013. Vol. 36, № 2. P. 348–354.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Couper JJ, Haller MJ, Greenbaum CJ, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Stages of type 1 diabetes in children and adolescents. Pediatr Diabetes. 2018;19:20-27. doi: https://doi.org/10.1111/pedi.12734</mixed-citation><mixed-citation xml:lang="en">Couper J.J. et al. ISPAD Clinical Practice Consensus Guidelines 2018: Stages of type 1 diabetes in children and adolescents // Pediatr. Diabetes. 2018. Vol. 19. P. 20–27.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Tuomilehto J, Podar T, Tuomilehto-Wolf E, Virtala E. Evidence for importance of gender and birth cohort for risk of IDDM in offspring of IDDM parents. Diabetologia. 1995. doi: https://doi.org/10.1007/BF00400588</mixed-citation><mixed-citation xml:lang="en">Tuomilehto J. et al. Evidence for importance of gender and birth cohort for risk of IDDM in offspring of IDDM parents // Diabetologia. 1995. Vol. 38, № 8. P. 975–982.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Weires M, Tausch B, Haug P, et al. Familiality of Diabetes Mellitus. Exp Clin Endocrinol Diabetes. 2007;115(10):634-640. doi: https://doi.org/10.1055/s-2007-984443</mixed-citation><mixed-citation xml:lang="en">Weires M. et al. Familiality of Diabetes Mellitus // Exp. Clin. Endocrinol. Diabetes. 2007. Vol. 115, № 10. P. 634–640.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Harjutsalo V, Reunanen A, Tuomilehto J. Differential transmission of type 1 diabetes from diabetic fathers and mothers to their offspring. Diabetes. 2006. doi: https://doi.org/10.2337/db05-1296</mixed-citation><mixed-citation xml:lang="en">Harjutsalo V., Reunanen A., Tuomilehto J. Differential Transmission of Type 1 Diabetes from Diabetic Fathers and Mothers to Their Offspring // Diabetes. 2006. Vol. 55, № 5. P. 1517–1524.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Harjutsalo V, Podar T, Tuomilehto J. Cumulative incidence of type 1 diabetes in 10,168 siblings of finnish young-onset type 1 diabetic patients. Diabetes. 2005. doi: https://doi.org/10.2337/diabetes.54.2.563</mixed-citation><mixed-citation xml:lang="en">Harjutsalo V., Podar T., Tuomilehto J. Cumulative Incidence of Type 1 Diabetes in 10,168 Siblings of F innish Young-Onset Type 1 Diabetic Patients // Diabetes. 2005. Vol. 54, № 2. P. 563–569.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Shaltout AA, Channanath AM, Thanaraj TA, et al. Ketoacidosis at first presentation of type 1 diabetes mellitus among children: a study from Kuwait. Sci Rep. 2016;6(1):27519. doi: https://doi.org/10.1038/srep27519</mixed-citation><mixed-citation xml:lang="en">Shaltout A.A. et al. Ketoacidosis at first presentation of type 1 diabetes mellitus among children: a study from Kuwait // Sci. Rep. 2016. Vol. 6, № 1. P. 27519.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Warram JH, Krolewski AS, Gottlieb MS, Kahn CR. Differences in Risk of Insulin-Dependent Diabetes in Offspring of Diabetic Mothers and Diabetic Fathers. N Engl J Med. 1984. doi: https://doi.org/10.1056/nejm198407193110304</mixed-citation><mixed-citation xml:lang="en">Warram J.H. et al. Differences in Risk of Insulin-Dependent Diabetes in Offspring of Diabetic Mothers and Diabetic Fathers // N. Engl. J. Med. 1984. Vol. 311, № 3. P. 149–152.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Familial risk of type I diabetes in European children. The Eurodiab Ace Study Group and The Eurodiab Ace Substudy 2 Study Group [published correction appears in Diabetologia 1999 Feb;42(2):262]. Diabetologia. 1998;41(10):1151-1156. doi: https://doi.org/10.1007/s001250051044</mixed-citation><mixed-citation xml:lang="en">Familial Risk of Type I diabetes in European Children // Diabetologia. 1998. Vol. 41, № 10. P. 1151–1156.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Herold KC, Bundy BN, Long SA, et al. An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. N Engl J Med. 2019. doi: https://doi.org/10.1056/nejmoa1902226</mixed-citation><mixed-citation xml:lang="en">Herold K.C. et al. An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes // N. Engl. J. Med. 2019. Vol. 381, № 7. P. 603–613.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">O’Leary LA, Dorman JS, LaPorte RE, et al. Familial and sporadic insulin-dependent diabetes: evidence for heterogeneous etiologies? Diabetes Res Clin Pract. 1991;14(3):183-190. doi: https://doi.org/10.1016/0168-8227(91)90019-A</mixed-citation><mixed-citation xml:lang="en">O’Leary L.A. et al. Familial and sporadic insulin-dependent diabetes: evidence for heterogeneous etiologies? // Diabetes Res. Clin. Pract. 1991. Vol. 14, № 3. P. 183–190.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Veijola R, Reijonen H, Vähäsalo P, et al. HLA-DQB1-defined genetic susceptibility, beta cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus. J Clin Invest. 1996. doi: https://doi.org/10.1172/JCI119067</mixed-citation><mixed-citation xml:lang="en">Veijola R. et al. HLA-DQB1-defined genetic susceptibility, beta cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group. // J. Clin. Invest. 1996. Vol. 98, № 11. P. 2489–2495.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lebenthal Y, De Vries L, Phillip M, Lazar L. Familial type 1 diabetes mellitus - gender distribution and age at onset of diabetes distinguish between parent-offspring and sib-pair subgroups. Pediatr Diabetes. 2010;11(6):403-411. doi: https://doi.org/10.1111/j.1399-5448.2009.00621.x</mixed-citation><mixed-citation xml:lang="en">Lebenthal Y. et al. Familial type 1 diabetes mellitus - gender distribution and age at onset of diabetes distinguish between parent-offspring and sib-pair subgroups // Pediatr. Diabetes. 2010. Vol. 11, № 6. P. 403–411.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Gillespie KM, Aitken RJ, Wilson I, Williams AJK, Bingley PJ. Early Onset of Diabetes in the Proband Is the Major Determinant of Risk in HLA DR3-DQ2/DR4-DQ8 Siblings. Diabetes. 2014;63(3):1041-1047. doi: https://doi.org/10.2337/db13-0994</mixed-citation><mixed-citation xml:lang="en">Gillespie K.M. et al. Early Onset of Diabetes in the Proband Is the Major Determinant of Risk in Hla Dr3-Dq2/Dr4-Dq8 Siblings // Diabetes. 2014. Vol. 63, № 3. P. 1041–1047.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Redondo MJ, Geyer S, Steck AK, et al. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk. Diabetes Care. 2018;41(9):1887-1894. doi: https://doi.org/10.2337/dc18-0087</mixed-citation><mixed-citation xml:lang="en">Redondo M.J. et al. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk // Diabetes Care. 2018. Vol. 41, № 9. P. 1887–1894.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Tillil H, Köbberling J. Age-Corrected Empirical Genetic Risk Estimates for First-Degree Relatives of IDDM Patients. Diabetes. 1987;36(1):93-99. doi: https://doi.org/10.2337/diab.36.1.93</mixed-citation><mixed-citation xml:lang="en">Tillil H., Köbberling J. Age-Corrected Empirical Genetic Risk Estimates for First-Degree Relatives of IDDM Patients // Diabetes. 1987. Vol. 36, № 1. P. 93–99.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Redondo MJ, Jeffrey J, Fain PR, et al. Concordance for Islet Autoimmunity among Monozygotic Twins. N Engl J Med. 2008;359(26):2849-2850. doi: https://doi.org/10.1056/NEJMc0805398</mixed-citation><mixed-citation xml:lang="en">Redondo M.J. et al. Concordance for Islet Autoimmunity among Monozygotic Twins // N. Engl. J. Med. 2008. Vol. 359, № 26. P. 2849–2850.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Turtinen M, Härkönen T, Parkkola A, et al. Characteristics of familial type 1 diabetes: effects of the relationship to the affected family member on phenotype and genotype at diagnosis. Diabetologia. 2019;62(11):2025-2039. doi: https://doi.org/10.1007/s00125-019-4952-8</mixed-citation><mixed-citation xml:lang="en">the Finnish Pediatric Diabetes Register et al. Characteristics of familial type 1 diabetes: effects of the relationship to the affected family member on phenotype and genotype at diagnosis // Diabetologia. 2019. Vol. 62, № 11. P. 2025–2039.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Zung A, Na’amnih W, Bluednikov Y, et al.; Israel IDDM Registry Study Group (IRRSG). The proportion of familial cases of type 1 diabetes is increasing simultaneously with the disease incidence: Eighteen years of the Israeli Pediatric Diabetes Registry. Pediatr Diabetes. 2018;19(4):693-698. doi: https://doi.org/10.1111/pedi.12617</mixed-citation><mixed-citation xml:lang="en">Zung A. et al. The proportion of familial cases of type 1 diabetes is increasing simultaneously with the disease incidence: Eighteen years of the Israeli Pediatric Diabetes Registry // Pediatr. Diabetes. 2018. Vol. 19, № 4. P. 693–698.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Karges B, Prinz N, Placzek K, et al. A Comparison of Familial and Sporadic Type 1 Diabetes Among Young Patients. Diabetes Care. 2021;44(5):1116-1124. doi: https://doi.org/10.2337/dc20-1829</mixed-citation><mixed-citation xml:lang="en">Karges B. et al. A Comparison of Familial and Sporadic Type 1 Diabetes Among Young Patients // Diabetes Care. 2021. Vol. 44, № 5. P. 1116–1124.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Umpierrez GE, Latif KA, Murphy MB, et al. Thyroid Dysfunction in Patients With Type 1 Diabetes. Diabetes Care. 2003;26(4):1181-1185. doi: https://doi.org/10.2337/diacare.26.4.1181</mixed-citation><mixed-citation xml:lang="en">Umpierrez G.E. et al. Thyroid Dysfunction in Patients With Type 1 Diabetes // Diabetes Care. 2003. Vol. 26, № 4. P. 1181–1185.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Brenta G. Diabetes and thyroid disorders. Br J Diabetes Vasc Dis. 2010;10(4):172-177. doi: https://doi.org/10.1177/1474651410371321</mixed-citation><mixed-citation xml:lang="en">Brenta G. Diabetes and thyroid disorders // Br. J. Diabetes Vasc. Dis. 2010. Vol. 10, № 4. P. 172–177.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Fox LA, Mubasher M, Wolfsdorf JI, et al. Characteristics of youth with type 1 diabetes (T1D) with and without a parent with T1D in the T1D exchange clinic registry. J Diabetes. 2016;8(6):834-838. doi: https://doi.org/10.1111/1753-0407.12363</mixed-citation><mixed-citation xml:lang="en">Fox L.A. et al. Characteristics of youth with type 1 diabetes (T1D) with and without a parent with T1D in the T1D exchange clinic registry: 在1型糖尿病(type 1 diabetes,T1D)临床交流记录本中有1名父母合并或者不合并T1D的年轻T1D患者的特征 // J. Diabetes. 2016. Vol. 8, № 6. P. 834–838.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Lebenthal Y, Shalitin S, Yackobovitch-Gavan M, et al. Retrospective comparative analysis of metabolic control and early complications in familial and sporadic type 1 diabetes patients. J Diabetes Complications. 2012;26(3):219-224. doi: https://doi.org/10.1016/j.jdiacomp.2012.03.016</mixed-citation><mixed-citation xml:lang="en">Lebenthal Y. et al. Retrospective comparative analysis of metabolic control and early complications in familial and sporadic type 1 diabetes patients // J. Diabetes Complications. 2012. Vol. 26, № 3. P. 219–224.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Enczmann J, Balz V, Hoffmann M, et al. Next Generation Sequencing Identifies the HLA-DQA1*03:03 Allele in the Type 1 Diabetes Risk-Associated HLA-DQ8 Serotype. Genes (Basel). 2021;12(12):1879. doi: https://doi.org/10.3390/genes12121879</mixed-citation><mixed-citation xml:lang="en">Enczmann J. et al. Next Generation Sequencing Identifies the HLA-DQA1*03:03 Allele in the Type 1 Diabetes Risk-Associated HLA-DQ8 Serotype // Genes. 2021. Vol. 12, № 12. P. 1879.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
